# Roflumilast to Treat Cognitive Sequela After Stroke

> **NCT04854811** · PHASE2 · COMPLETED · sponsor: **Maastricht University** · enrollment: 100 (actual)

## Conditions studied

- Cerebrovascular Disorders
- Memory
- Functional Recovery
- Drug Intervention

## Interventions

- **DRUG:** Roflumilast Oral Tablet

## Key facts

- **NCT ID:** NCT04854811
- **Lead sponsor:** Maastricht University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-07
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854811, "Roflumilast to Treat Cognitive Sequela After Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04854811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*